Medication info
Mavix Tablet (Memantine Hydrochloride)

Mavix Tablet (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Austin Pharmaceuticals Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200501860 · Notified 2005.12.07 · Insurance code 654300860

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7): Administer 5mg daily for 7 days. Week 2 (Days 8–14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (Days 15–21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From Week 4 onward: Administer 20mg daily (10mg twice daily). The recommended maintenance dose is 20mg daily (10mg twice daily). The recommended dose for elderly patients aged 65 years and older is 20mg daily (10mg twice daily). No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), the daily dose should be reduced to 10mg. No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Ingredients

Manufacturer
Austin Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medicine is used to treat moderate to severe Alzheimer's disease. Alzheimer's disease is a condition characterized by a gradual decline in memory and cognitive functions, and this medication helps alleviate symptoms. Therefore, it contributes to improving the patient's cognitive function and maintaining their ability to perform daily activities. It is effectively used for patients with moderate to severe stages of Alzheimer's disease.

How to take

Adult dose

The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7): Administer 5mg daily for 7 days. Week 2 (Days 8–14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (Days 15–21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From Week 4 onward: Administer 20mg daily (10mg twice daily). The recommended maintenance dose is 20mg daily (10mg twice daily). The recommended dose for elderly patients aged 65 years and older is 20mg daily (10mg twice daily). No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), the daily dose should be reduced to 10mg. No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Precautions

This medication should not be used in patients who are allergic to its components. It should also not be administered to patients with very poor liver function or severely impaired kidney function. This medication contains lactose, so patients with a genetic disorder that prevents lactose from being digested should not take it. Caution is necessary for patients with a history of seizures or convulsions, or those at high risk for seizures while using this medication. The risk of side effects may increase when combined with certain other medications, so it is essential to consult a doctor. Patients with changes in urine acidity should be closely monitored while using this medication. Patients with heart disease or uncontrolled hypertension should exercise special caution when using this medication. While taking this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, so patients should be closely monitored. Women who are pregnant or may become pregnant should definitely consult a doctor before taking this medication, and nursing mothers are advised to discontinue breastfeeding. The safety and effectiveness of this medication in children or adolescents under 18 years old have not been established. In case of overdose, central nervous system symptoms or gastrointestinal symptoms may emerge, so immediate contact with a medical institution is necessary, and there are no specific antidotes; treatment will be based on the symptoms. This medication may slow the patient's mental response time, so caution is required when driving or operating machinery. Keep out of reach of children, and avoid transferring the medication to another container.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucination
  • psychotic reaction
Show 24 more
  • balance impairment
  • gait abnormality
  • seizure
  • heart failure
  • venous thrombosis/thromboembolism
  • shortness of breath
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • anxiety
  • aggression
  • stupor
  • unconsciousness
  • restlessness
  • psychosis
  • visual hallucination
  • convulsion
  • coma
  • double vision

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius (room temperature). This will ensure that the components of the medication do not change and can be used safely.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.